DE69226491T2 - Verbesserung der Durchdringungfähigkeit von topischen Anwendbaren Formulierungen - Google Patents

Verbesserung der Durchdringungfähigkeit von topischen Anwendbaren Formulierungen

Info

Publication number
DE69226491T2
DE69226491T2 DE69226491T DE69226491T DE69226491T2 DE 69226491 T2 DE69226491 T2 DE 69226491T2 DE 69226491 T DE69226491 T DE 69226491T DE 69226491 T DE69226491 T DE 69226491T DE 69226491 T2 DE69226491 T2 DE 69226491T2
Authority
DE
Germany
Prior art keywords
penetrability
improving
topical formulations
vitamin
penetration
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Revoked
Application number
DE69226491T
Other languages
English (en)
Other versions
DE69226491D1 (de
Inventor
Joseph Synodis
Stuart Wilensky
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Stafford Miller Continental NV
Original Assignee
Stafford Miller Continental NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25135484&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE69226491(T2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Stafford Miller Continental NV filed Critical Stafford Miller Continental NV
Publication of DE69226491D1 publication Critical patent/DE69226491D1/de
Application granted granted Critical
Publication of DE69226491T2 publication Critical patent/DE69226491T2/de
Anticipated expiration legal-status Critical
Revoked legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355—Tocopherols, e.g. vitamin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE69226491T 1991-10-23 1992-10-23 Verbesserung der Durchdringungfähigkeit von topischen Anwendbaren Formulierungen Revoked DE69226491T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US78542691A 1991-10-23 1991-10-23

Publications (2)

Publication Number Publication Date
DE69226491D1 DE69226491D1 (de) 1998-09-10
DE69226491T2 true DE69226491T2 (de) 1999-01-14

Family

ID=25135484

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69226491T Revoked DE69226491T2 (de) 1991-10-23 1992-10-23 Verbesserung der Durchdringungfähigkeit von topischen Anwendbaren Formulierungen

Country Status (11)

Country Link
US (1) US6017520A (de)
EP (1) EP0539215B1 (de)
JP (1) JP2671248B2 (de)
KR (1) KR930007445A (de)
AT (1) ATE169228T1 (de)
AU (1) AU658681B2 (de)
CA (1) CA2081269C (de)
DE (1) DE69226491T2 (de)
DK (1) DK0539215T3 (de)
ES (1) ES2119800T3 (de)
NZ (1) NZ244862A (de)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2161004C (en) * 1993-04-20 2004-10-26 Wilfried Fischer Active ingredient patch
WO1995030420A1 (en) * 1994-05-06 1995-11-16 Alcon Laboratories, Inc. Use of vitamin e tocopheryl derivatives in ophthalmic compositions
GB9409778D0 (en) 1994-05-16 1994-07-06 Dumex Ltd As Compositions
WO1996020712A1 (en) * 1994-12-30 1996-07-11 American Home Products Corporation Clear non-alcoholic hydrocortisone solutions
ATE249819T1 (de) 1995-04-21 2003-10-15 Seikisui Chemical Co Ltd Präparate zur äusserlichen anwendung zur behandlung von dermatosen
ES2177948T3 (es) * 1996-03-14 2002-12-16 Johnson & Johnson Consumer Composiciones de tensioactivos limpiadoras e hidratantes.
US6730679B1 (en) 1996-03-22 2004-05-04 Smithkline Beecham Corporation Pharmaceutical formulations
IT1282778B1 (it) * 1996-05-31 1998-03-31 Giorgio Panin Vitamina "e" acetato quale prodotto per applicazione topica
DE19646392A1 (de) * 1996-11-11 1998-05-14 Lohmann Therapie Syst Lts Zubereitung zur Anwendung in der Mundhöhle mit einer an der Schleimhaut haftklebenden, Pharmazeutika oder Kosmetika zur dosierten Abgabe enthaltenden Schicht
AUPO379596A0 (en) * 1996-11-22 1996-12-19 Soltec Research Pty Ltd Percutaneous delivery system
US20040067212A1 (en) * 1998-03-11 2004-04-08 Kabushiki Kaisha Soken Skin conditioner
KR20000000840A (ko) * 1998-06-03 2000-01-15 김영대 신규한 폴리옥시프로필렌폴리옥시에틸렌 비타민 e 및 그의제조방법
FR2761600B1 (fr) 1998-06-19 2000-03-31 Oreal Composition moussante pour le lavage et le traitement des cheveux et/ou du cuir chevelu a base d'un principe actif, d'un tensioactif anionique, d'un tensioactif amphotere et d'un agent propenetrant
US20070191320A1 (en) * 1998-12-10 2007-08-16 Nexmed Holdings, Inc. Methods of treatment for female sexual arousal disorder
US6486207B2 (en) 1998-12-10 2002-11-26 Nexmed (Holdings), Inc. Compositions and methods for amelioration of human female sexual dysfunction
US6825234B2 (en) 1998-12-10 2004-11-30 Nexmed (Holdings) , Inc. Compositions and methods for amelioration of human female sexual dysfunction
AU769065B2 (en) * 1999-02-12 2004-01-15 Procter & Gamble Company, The Cosmetic compositions containing vitamin B3 compounds
US6787342B2 (en) * 2000-02-16 2004-09-07 Merial Limited Paste formulations
US6383505B1 (en) 2000-11-09 2002-05-07 Steris Inc Fast-acting antimicrobial lotion with enhanced efficacy
US6429231B1 (en) * 2001-09-24 2002-08-06 Bradley Pharmaceuticals, Inc. Compositions containing antimicrobials and urea for the treatment of dermatological disorders and methods for their use
DE60325718D1 (de) * 2002-05-06 2009-02-26 Elan Pharma Int Ltd Nystatin-nanopartikelzusammensetzungen
CA2487882A1 (en) * 2002-05-31 2003-12-11 University Of Mississippi Transmucosal delivery of cannabinoids
DE10224612A1 (de) * 2002-06-04 2003-12-24 Lohmann Therapie Syst Lts Wirkstoffhaltige filmförmige Zubereitungen mit verbesserter chemischer Stabilität, und Verfahren zu deren Herstellung
JP2004123633A (ja) * 2002-10-03 2004-04-22 Medorekkusu:Kk 外用製剤
US7374772B2 (en) * 2002-11-07 2008-05-20 Bommarito Alexander A Topical antifungal treatment
US20040191279A1 (en) * 2003-03-28 2004-09-30 Klofta Thomas James Tacky skin care compositions and articles having tacky skin care compositions disposed thereon
KR100782890B1 (ko) * 2003-10-03 2007-12-06 더 프록터 앤드 갬블 캄파니 국소 조성물
US9314431B2 (en) * 2005-02-14 2016-04-19 Transdermal Corp Solubilized benzoyl small molecule
US9308268B2 (en) * 2005-02-14 2016-04-12 Transdermal Corp Solubilized benzoyl peroxyde acne
US20090304820A1 (en) * 2008-06-05 2009-12-10 Pankaj Modi Solubilized benzoyl peroxide topical drug formulation for the treatment of acne
US7563464B1 (en) * 2005-04-22 2009-07-21 Bruce Eric Hudkins Treatment of mucosal membranes utilizing phytoestrogen
WO2008037809A1 (en) * 2006-09-29 2008-04-03 Abbott Gmbh & Co. Kg Transmucosal administration of fibrate compounds and delivery system therefor
CA2719512A1 (en) 2010-11-01 2012-05-01 Stiefel Research Australia Pty Ltd Polymeric topical compositions
WO2018122344A1 (en) 2016-12-29 2018-07-05 Nestlé Skin Health Sa Composition comprising a crosslinked hyaluronic acid (ha) in combination with a low-molecular ha and/or an agent stimulating endogenous ha synthesis

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4177267A (en) * 1963-12-09 1979-12-04 Crown Zellerbach Enhancing tissue penetration of physiologically active steroidal agents with DMSC
IN142640B (de) * 1975-01-17 1977-08-06 Johnson & Johnson
JPS5579318A (en) * 1978-12-07 1980-06-14 Taisho Pharmaceut Co Ltd Poultice
JPS5610887A (en) * 1979-07-09 1981-02-03 Babcock Hitachi Kk Handrall structure of joint portion of duct
JPS5855417A (ja) * 1981-09-27 1983-04-01 Nitto Electric Ind Co Ltd 医薬組成物
DE3579343D1 (de) * 1984-03-07 1990-10-04 Roshdy Ismail Mittel zur behandlung und zum schutz der haut.
JPS60224638A (ja) * 1984-04-23 1985-11-09 Kao Corp 経皮吸収促進剤およびこれを含有する外用剤
US4824676A (en) * 1984-10-11 1989-04-25 Schering Corporation Physiological means of enhancing transdermal delivery of drugs
US4886783A (en) * 1986-01-31 1989-12-12 Nelson Research & Development Co. Penetration enhancers for transdermal delivery of systemic agents
US4917896A (en) * 1986-08-15 1990-04-17 Nelson Research & Development Co. Penetration enhancers for transdermal delivery of systemic agents
US4808414A (en) * 1986-09-29 1989-02-28 Nelson Research & Development Co. Amide penetration enhancers for transdermal delivery of systemic agents
GB8630721D0 (en) * 1986-12-23 1987-02-04 Unilever Plc Cosmetic compositions
US4869897A (en) * 1987-10-22 1989-09-26 The Procter & Gamble Company Photoprotection compositions comprising sorbohydroxamic acid
US4847069A (en) * 1987-10-22 1989-07-11 The Procter & Gamble Company Photoprotection compositions comprising sorbohydroxamic acid and an anti-inflammatory agent
JP2663136B2 (ja) * 1988-05-02 1997-10-15 有限会社野々川商事 美白化粧料
EP0356382B1 (de) * 1988-08-02 1994-02-16 Ciba-Geigy Ag Mehrschichtiges Pflaster
EP0576605A4 (en) * 1991-03-19 1994-06-08 Vithal J Rajadhyaksha Compositions and method comprising aminoalcohol derivatives as membrane penetration enhancers
US5215759A (en) * 1991-10-01 1993-06-01 Chanel, Inc. Cosmetic composition

Also Published As

Publication number Publication date
CA2081269A1 (en) 1993-04-24
JPH06128176A (ja) 1994-05-10
CA2081269C (en) 2002-03-05
US6017520A (en) 2000-01-25
NZ244862A (en) 1995-07-26
ES2119800T3 (es) 1998-10-16
DE69226491D1 (de) 1998-09-10
EP0539215A1 (de) 1993-04-28
JP2671248B2 (ja) 1997-10-29
EP0539215B1 (de) 1998-08-05
DK0539215T3 (da) 1999-05-03
AU658681B2 (en) 1995-04-27
AU2726692A (en) 1993-04-29
KR930007445A (ko) 1993-05-20
ATE169228T1 (de) 1998-08-15

Similar Documents

Publication Publication Date Title
DE69226491D1 (de) Verbesserung der Durchdringungfähigkeit von topischen Anwendbaren Formulierungen
RU93047799A (ru) Композиции, содержащие ретиноевые кислоты и токоферол
DE3579128D1 (de) 13-cis-vitamin-a-saeure als wirksubstanz enthaltende arzneimittel.
MX9304710A (es) Composicion farmaceutica y/o cosmetica y su uso.
DE69315927T2 (de) Kosmetische Zusammensetzung, die einen Lipidstoff und eine Hydroxy - oder Ketofettsäure enthält
ATE6988T1 (de) Antimykotische mittel mit hoher wirkstofffreisetzung in form von stiften.
ATE67667T1 (de) Neue topische metronidazol-formulierungen.
ATE98868T1 (de) Topisch kosmetisch anzuwendende depolymerisierte nukleinsaeuren enthaltende arzneizubereitungen.
ATE29382T1 (de) Arzneimittel zur behandlung von haarausfall.
KR910005876A (ko) 모세혈관 취약증의 치료를 위한 극소용 약학적 조성물
CA2210674A1 (fr) Nouvelles compositions topiques comprenant de tres faibles doses de melatonine ou ses derives et leur utilisation en cosmetique
IT7949034A0 (it) Perfezionamento nelle composizioni emollienti per emulsioni creme paste cosmetiche e simili
AU629445B2 (en) Improvements in or relating to topical compositions containing 1 alpha 25-dihydroxycholecalciferol
ES545063A0 (es) Producto antiseptico
DE50010067D1 (de) Kosmetische oder pharmazeutische Zubereitungen für die topische Verabreichung mit verbesserter Stabilität
FR2360313A1 (fr) Compositions pharmaceutiques utiles notamment pour le traitement de la seborrhee
ATE271872T1 (de) Topische carbamazepin-formulierungen und deren verwendung
GB2184652B (en) Topical compositions containing hexyl nicotinate

Legal Events

Date Code Title Description
8363 Opposition against the patent
8331 Complete revocation